WallStSmart
CNTA

Centessa Pharmaceuticals PLC ADR

NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY

$39.45
-0.03% today

Updated 2026-04-29

Market cap
$6.10B
P/E ratio
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
52W range
$11 – $40
Volume
3.0M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
2.5
Profitability
F
5.0
Valuation
C+
5/9
Piotroski F-Score
Moderate
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$44.57
+12.98%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Debt/equity 0.39x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-55.82M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$6.85M$0.00$15.00M$15.00M
Net income$-216.21M$-151.09M$-235.76M$-197.53M$-66.16M
EPS$-1.46
Free cash flow$-201.68M$-160.51M$-142.09M$-194.19M$-55.82M
Profit margin-2,204.65%-1,316.88%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CNTA$6.10B244.32.55.07.3Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Centessa Pharmaceuticals PLC ADR trades at $39.45. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $15.00M.

Frequently asked questions

What is Centessa Pharmaceuticals PLC ADR's stock price?
Centessa Pharmaceuticals PLC ADR (CNTA) trades at $39.45.
Is Centessa Pharmaceuticals PLC ADR overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Centessa Pharmaceuticals PLC ADR (CNTA)?
The analyst target price is $44.57, representing +13.0% upside from the current price of $39.45.
What is Centessa Pharmaceuticals PLC ADR's revenue?
TTM revenue is $15.00M.
Piotroski F-Score?
5/9 — moderate financial health.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio406.76x
ROE-42.50%
Beta1.26
50D MA$32.29
200D MA$24.92
Shares out0.15B
Float0.10B
Short ratio
Avg volume3.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years